Add Company
Join Now

Recordati Rare Diseases Revenue and Competitors

License our Company Data API

Puteaux, USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Recordati Rare Diseases's estimated annual revenue is currently $76.4M per year.(i)
  • Recordati Rare Diseases's estimated revenue per employee is $201,000

Employee Data

  • Recordati Rare Diseases has 380 Employees.(i)
  • Recordati Rare Diseases grew their employee count by 34% last year.

Recordati Rare Diseases's People

NameTitleEmail/Phone
1
Manufacturing Industrial Operations Manager / Site HeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Recordati Rare Diseases?

At Recordati Rare Diseases, we focus on the few - those affected by rare diseases. We believe that every single patient has the right to the best possible treatment. Patients with rare diseases are our top priority. They are at the core of our planning, our thinking and our actions.

keywords:N/A

N/A

Total Funding

380

Number of Employees

$76.4M

Revenue (est)

34%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Recordati Rare Diseases News

2022-04-20 - Nephropathic Cystinosis Treatment Market Size And Forecast ...

... Chiesi Farmaceutici SpA, Leadiant Biosciences Eloxx Pharmaceuticals, GlaxoSmithKline plc., Recordati Rare Diseases, AVROBIO, Inc.

2022-03-30 - Recordati Rare Diseases Announce Publication in the Journal ...

Recordati Rare Diseases Announce Publication in the Journal of Clinical Endocrinology & Metabolism of the Phase III LINC 4 Study Confirming the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$131.8M51722%N/A
#2
$136.5M5207%N/A
#3
N/A5967%N/A
#4
$15M9069%N/A
#5
$3.5M11724%N/A